BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7886015)

  • 1. [Histopathology and clinical aspects of primary myelodysplastic syndrome].
    Maschek H; Georgii A
    Pathologe; 1995 Jan; 16(1):53-61. PubMed ID: 7886015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The implications of revised WHO classification (2008) of chronic myeloid neoplasms.
    Găman M; Vlădăreanu AM; Radesi S
    Rom J Intern Med; 2011; 49(1):25-30. PubMed ID: 22026249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myelodysplastic syndromes--from FAB to WHO classification].
    Kotlarek-Haus S; Haus O
    Pol Arch Med Wewn; 2005 Nov; 114(5):1128-37. PubMed ID: 16789514
    [No Abstract]   [Full Text] [Related]  

  • 5. Life expectancy in primary myelodysplastic syndromes: a prognostic score based upon histopathology from bone marrow biopsies of 569 patients.
    Maschek H; Gutzmer R; Choritz H; Georgii A
    Eur J Haematol; 1994 Nov; 53(5):280-7. PubMed ID: 7813708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphologic classification of the myelodysplastic syndromes (MDS): combined utilization of bone marrow aspirates and trephine biopsies.
    Bartl R; Frisch B; Baumgart R
    Leuk Res; 1992; 16(1):15-33. PubMed ID: 1732665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathology of myelodysplastic syndromes. The FAB classification (proposals) applied to bone marrow biopsy.
    Delacrétaz F; Schmidt PM; Piguet D; Bachmann F; Costa J
    Am J Clin Pathol; 1987 Feb; 87(2):180-6. PubMed ID: 3812349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Issues in the pathology of the myelodysplastic syndromes.
    Kampmeier P; Anastasi J; Vardiman JW
    Hematol Oncol Clin North Am; 1992 Jun; 6(3):501-22. PubMed ID: 1613003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contemporary possibilities of prognosis in myelodysplastic syndromes].
    Goździk J; Lewandowski K; Hansz J
    Acta Haematol Pol; 1995; 26(2):129-38. PubMed ID: 7653217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative review of classification systems in myelodysplastic syndromes (MDS).
    Bennett JM
    Semin Oncol; 2005 Aug; 32(4 Suppl 5):S3-10. PubMed ID: 16085011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic relevance of histological findings on bone marrow biopsy in myelodysplastic syndromes.
    Lambertenghi-Deliliers G; Annaloro C; Oriani A; Soligo D; Pozzoli E; Polli EE
    Ann Hematol; 1993 Feb; 66(2):85-91. PubMed ID: 8448244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression, transformation, and unusual manifestations of myelodysplastic syndromes and myelodysplastic-myeloproliferative neoplasms: lessons learned from the XIV European Bone Marrow Working Group Course 2019.
    Hebeda K; Boudova L; Beham-Schmid C; Orazi A; Kvasnicka HM; Gianelli U; Tzankov A
    Ann Hematol; 2021 Jan; 100(1):117-133. PubMed ID: 33128619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoplastic myelodysplastic syndrome: incidence, morphology, cytogenetics, and prognosis.
    Maschek H; Kaloutsi V; Rodriguez-Kaiser M; Werner M; Choritz H; Mainzer K; Dietzfelbinger M; Georgii A
    Ann Hematol; 1993 Mar; 66(3):117-22. PubMed ID: 8471656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic myelomonocytic leukaemia (CMML)--a myelodysplastic or myeloproliferative syndrome?
    Michaux JL; Martiat P
    Leuk Lymphoma; 1993 Jan; 9(1-2):35-41. PubMed ID: 8477199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelodysplastic syndromes, chronic myeloproliferative diseases, and myelodysplastic/myeloproliferative diseases.
    Vardiman JW
    Semin Diagn Pathol; 2003 Aug; 20(3):154-79. PubMed ID: 14552429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Panmyelopathy and myeloproliferative syndrome].
    Jorke D; Bach G
    Z Gesamte Inn Med; 1986 Nov; 41(21):595-8. PubMed ID: 3469815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of risk groups in myelodysplastic syndromes. A multicenter study.
    Belli C; Acevedo S; Bengio R; Arrossagaray G; Watman N; Rossi N; García J; Flores G; Goldztein S; Larripa I
    Haematologica; 2002 Jan; 87(1):9-16. PubMed ID: 11801460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow niches in myeloid neoplasms.
    Kitagawa M; Kurata M; Onishi I; Yamamoto K
    Pathol Int; 2020 Feb; 70(2):63-71. PubMed ID: 31709722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Histopathologic diagnosis of bone marrow in leukemia and related disorders].
    Kikuchi M; Ohshima K; Kobari S
    Rinsho Byori; 1991 Dec; 39(12):1245-9. PubMed ID: 1779461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytogenetic examination of bone marrow cells in stem cell diseases of myelodysplastic syndromes].
    Werner M; Maschek HJ; Kaloutsi V; Buhr T; Kausche F; Delventhal S; Georgii A
    Verh Dtsch Ges Pathol; 1990; 74():139-43. PubMed ID: 1708572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.